1.Thyroid Cancer: We Need a Carcinogen-specific Genome Study.
Journal of Korean Medical Science 2015;30(12):1920-1921
3.Colorectal adenocarcinoma as a second malignant neoplasm following rhabdomyosarcoma of the urinary bladder: a case report.
Sung Shin PARK ; Byoung Kwon KIM ; Chong Jai KIM ; Woo Sun KIM ; In One KIM ; Kwi Won PARK ; Hee Young SHIN ; Hyo Seop AHN
Journal of Korean Medical Science 2000;15(4):475-477
Following improvements in therapy for childhood malignancies, the striking increase in survival rate over the past 30 years has led to the increase risk of developing second malignant neoplasms (SMNs). We report a case of colorectal carcinoma as a SMN, following treatment for rhabdomyosarcoma. The patient was diagnosed with rhabdomyosarcoma of the urinary bladder at his age of three years, and developed adenocarcinoma in the colon 13 years later. Histologic examination of the surgical specimen revealed adenocarcinoma involving the rectosigmoid area with radiation colitis in its background. The tumor cells showed strong immunoreactivity for p53 protein, suggesting the role of irradiation and p53 mutation in carcinogenesis. This case emphasizes the need for dose observation in survivors of early childhood malignancies treated with radiation and multiagent chemotherapy.
Adenocarcinoma/pathology
;
Adenocarcinoma/genetics
;
Adenocarcinoma/etiology+ACo-
;
Adolescence
;
Antineoplastic Agents, Combined/therapeutic use
;
Antineoplastic Agents, Combined/adverse effects+ACo-
;
Bladder Neoplasms+ACo-/radiotherapy
;
Bladder Neoplasms+ACo-/drug therapy
;
Case Report
;
Colitis/pathology
;
Colitis/etiology
;
Colorectal Neoplasms/pathology
;
Colorectal Neoplasms/genetics
;
Colorectal Neoplasms/etiology+ACo-
;
Combined Modality Therapy
;
Cyclophosphamide/adverse effects
;
Cyclophosphamide/administration +ACY- dosage
;
Doxorubicin/adverse effects
;
Doxorubicin/administration +ACY- dosage
;
Genes, p53
;
Human
;
Male
;
Neoplasm Proteins/analysis
;
Neoplasms, Radiation-Induced/pathology
;
Neoplasms, Radiation-Induced/genetics
;
Neoplasms, Radiation-Induced/etiology+ACo-
;
Neoplasms, Second Primary/etiology+ACo-
;
Protein p53/analysis
;
Radiation Injuries/pathology
;
Radiation Injuries/etiology
;
Radiotherapy/adverse effects+ACo-
;
Rhabdomyosarcoma+ACo-/radiotherapy
;
Rhabdomyosarcoma+ACo-/drug therapy
;
Sigmoid Neoplasms/pathology
;
Sigmoid Neoplasms/genetics
;
Sigmoid Neoplasms/etiology
;
Time Factors
;
Vincristine/adverse effects
;
Vincristine/administration +ACY- dosage
4.Colorectal adenocarcinoma as a second malignant neoplasm following rhabdomyosarcoma of the urinary bladder: a case report.
Sung Shin PARK ; Byoung Kwon KIM ; Chong Jai KIM ; Woo Sun KIM ; In One KIM ; Kwi Won PARK ; Hee Young SHIN ; Hyo Seop AHN
Journal of Korean Medical Science 2000;15(4):475-477
Following improvements in therapy for childhood malignancies, the striking increase in survival rate over the past 30 years has led to the increase risk of developing second malignant neoplasms (SMNs). We report a case of colorectal carcinoma as a SMN, following treatment for rhabdomyosarcoma. The patient was diagnosed with rhabdomyosarcoma of the urinary bladder at his age of three years, and developed adenocarcinoma in the colon 13 years later. Histologic examination of the surgical specimen revealed adenocarcinoma involving the rectosigmoid area with radiation colitis in its background. The tumor cells showed strong immunoreactivity for p53 protein, suggesting the role of irradiation and p53 mutation in carcinogenesis. This case emphasizes the need for dose observation in survivors of early childhood malignancies treated with radiation and multiagent chemotherapy.
Adenocarcinoma/pathology
;
Adenocarcinoma/genetics
;
Adenocarcinoma/etiology+ACo-
;
Adolescence
;
Antineoplastic Agents, Combined/therapeutic use
;
Antineoplastic Agents, Combined/adverse effects+ACo-
;
Bladder Neoplasms+ACo-/radiotherapy
;
Bladder Neoplasms+ACo-/drug therapy
;
Case Report
;
Colitis/pathology
;
Colitis/etiology
;
Colorectal Neoplasms/pathology
;
Colorectal Neoplasms/genetics
;
Colorectal Neoplasms/etiology+ACo-
;
Combined Modality Therapy
;
Cyclophosphamide/adverse effects
;
Cyclophosphamide/administration +ACY- dosage
;
Doxorubicin/adverse effects
;
Doxorubicin/administration +ACY- dosage
;
Genes, p53
;
Human
;
Male
;
Neoplasm Proteins/analysis
;
Neoplasms, Radiation-Induced/pathology
;
Neoplasms, Radiation-Induced/genetics
;
Neoplasms, Radiation-Induced/etiology+ACo-
;
Neoplasms, Second Primary/etiology+ACo-
;
Protein p53/analysis
;
Radiation Injuries/pathology
;
Radiation Injuries/etiology
;
Radiotherapy/adverse effects+ACo-
;
Rhabdomyosarcoma+ACo-/radiotherapy
;
Rhabdomyosarcoma+ACo-/drug therapy
;
Sigmoid Neoplasms/pathology
;
Sigmoid Neoplasms/genetics
;
Sigmoid Neoplasms/etiology
;
Time Factors
;
Vincristine/adverse effects
;
Vincristine/administration +ACY- dosage
5.Four Cases of Hematologic Malignancy Following Radioactive Iodine Therapy for Thyroid Cancer.
Mijeong IM ; Jin Kyung LEE ; Young Joon HONG ; Seok Il HONG ; Hye Jin KANG ; Im Il NA ; Baek Yeol RYOO ; Gi Jeong CHEON ; Ha Na LEE ; Yoon Hwan CHANG
The Korean Journal of Laboratory Medicine 2008;28(6):425-429
Ionizing radiation including I131 might produce chromosomal translocation, causing hematologic malignancy. The incidence of leukemia following radioactive iodine treatment for thyroid cancer has been reported to be approximately 0.1 to 2.0% in Western countries, whereas fewer cases have been reported in Korea. We hereby report four cases of secondary hematologic malignancy, who received iodine therapy for thyroid cancer after thyroidectomy: two cases of acute lymphoblastic leukemia with t(9;22)(q34;q11.2), a case of MDS with 5q deletion, and a case of MDS with normal karyotype. Three cases of hematologic malignancy have developed after cumulative dosage of less than 800 mCi. The treatment intervals in two cases were less than 12 months, and the other two cases had I131 therapy only once. Assessment of causality using the Naranjo probability scale for adverse drug reactions showed that a 'possible' relationship existed between the use of I131 and secondary hematologic malignancy in all of the four cases in this report.
Adult
;
Chromosomes, Human, Pair 22
;
Chromosomes, Human, Pair 5
;
Chromosomes, Human, Pair 9
;
Female
;
Gene Deletion
;
Hematologic Neoplasms/*diagnosis/genetics
;
Humans
;
Iodine Radioisotopes/*adverse effects/therapeutic use
;
Leukemia, Radiation-Induced/*diagnosis/etiology
;
Middle Aged
;
Myelodysplastic Syndromes/diagnosis/genetics
;
Neoplasms, Second Primary/*diagnosis/genetics
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma/diagnosis/genetics
;
Thyroid Neoplasms/*radiotherapy
;
Thyroidectomy
;
Translocation, Genetic